Evidence map›Paper›PMID 27616736›Full record

ArticleCellular & molecular immunology2018

VAMP2 is implicated in the secretion of antibodies by human plasma cells and can be replaced by other synaptobrevins.

Laura Gómez-Jaramillo, Raquel Romero-García, Gema Jiménez-Gómez, Lisa Riegle, Ana Belén Ramos-Amaya, José Antonio Brieva, Marie Kelly-Worden, Antonio Campos-Caro

Open access · greenAbstract read
In one paragraph

Article in Cellular & molecular immunology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Trehalose dimycolate inhibits phagosome maturation and promotes intracellularProceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Laura Gómez-JaramilloUnidad de Investigación, Hospital Universitario Puerta del Mar, Cádiz, Spain.
Raquel Romero-GarcíaUnidad de Investigación, Hospital Universitario Puerta del Mar, Cádiz, Spain.
Gema Jiménez-GómezUnidad de Investigación, Hospital Universitario Puerta del Mar, Cádiz, Spain.
Lisa RiegleDepartment of Biology, Ball State University, Muncie, IN, USA.
Ana Belén Ramos-AmayaUnidad de Investigación, Hospital Universitario Puerta del Mar, Cádiz, Spain.
José Antonio BrievaUnidad de Investigación, Hospital Universitario Puerta del Mar, Cádiz, Spain.
Marie Kelly-WordenDepartment of Biology, Ball State University, Muncie, IN, USA.
Antonio Campos-CaroUnidad de Investigación, Hospital Universitario Puerta del Mar, Cádiz, Spain. antonio.campos.caro.sspa@juntadeandalucia.es.
Hospital Universitario Puerta del Mar · ESBall State University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The production and secretion of antibodies by human plasma cells (PCs) are two essential processes of humoral immunity. The secretion process relies on a group of proteins known as soluble N-ethylmaleimide-sensitive factor attachment protein receptors (SNAREs), which are located in the plasma membrane (t-SNAREs) and in the antibody-carrying vesicle membrane (v-SNARE), and mediate the fusion of both membranes. We have previously shown that SNAP23 and STX4 are the t-SNAREs responsible for antibody secretion. Here, using human PCs and antibody-secreting cell lines, we studied and characterized the expression and subcellular distribution of vesicle associated membrane protein (VAMP) isoforms, demonstrating that all isoforms (with the exception of VAMP1) are expressed by the referenced cells. Furthermore, the functional role in antibody secretion of each expressed VAMP isoform was tested using siRNA. Our results show that VAMP2 may be the v-SNARE involved in vesicular antibody release. To further support this conclusion, we used tetanus toxin light chain to cleave VAMP2, conducted experiments to verify co-localization of VAMP2 in antibody-carrying vesicles, and demonstrated the coimmunoprecipitation of VAMP2 with STX4 and SNAP23 and the in situ interaction of VAMP2 with STX4. Taken together, these findings implicate VAMP2 as the main VAMP isoform functionally involved in antibody secretion.

Indexed as

AntibodiesCell LineCytoplasmic VesiclesGene SilencingHumansImmunoglobulin EPlasma CellsProtein DomainsProtein TransportQa-SNARE ProteinsQb-SNARE ProteinsQc-SNARE ProteinsRNA, Small InterferingTetanus ToxinVesicle-Associated Membrane Protein 2AntibodiesImmunoglobulin EQa-SNARE ProteinsQb-SNARE ProteinsQc-SNARE ProteinsRNA, Small InterferingSNAP23 protein, humansyntaxin 4, humanTetanus ToxinVesicle-Associated Membrane Protein 2exocytosishumanimmunoglobulinplasma cellsVAMP proteins

Identifiers

PMID27616736
PMCPMC6052834
OpenAlexW2520007230

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.